<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00624910</url>
  </required_header>
  <id_info>
    <org_study_id>INN-CB-002</org_study_id>
    <nct_id>NCT00624910</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of a Collagen Bupivacaine Implant in Women Following Abdominal Hysterectomy</brief_title>
  <official_title>A Phase II, Single-dose, Blinded, Prospective Study to Investigate the Efficacy and Safety of the CollaRx® Bupivacaine Implant in Women Following Abdominal Hysterectomy or Other Nonlaparoscopic Benign Gynecological Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Innocoll</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Premier Research Group plc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Innocoll</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the CollaRx Bupivacaine implant is safe and&#xD;
      effective in reducing the amount of narcotic pain medication needed to control pain during&#xD;
      the first 24 hours after abdominal hysterectomy surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hysterectomy is the second most common surgery among women in the United States (US).&#xD;
      According to the National Center for Health Statistics, there were 617,000 hysterectomies&#xD;
      performed in the US in 2004. Effective postoperative pain management after hysterectomy is&#xD;
      important in ensuring that surgical subjects have a smooth and successful recovery after&#xD;
      their operation. Morphine and other narcotic pain medications are often used to help control&#xD;
      pain after hysterectomy, but the large quantities required can lead to fatigue, nausea and&#xD;
      vomiting, as well as the inability to walk around much because of drowsiness. Reducing&#xD;
      narcotic pain medication use can reduce these negative side effects.&#xD;
&#xD;
      Bupivacaine is a local anesthetic (pain medicine) that has an established safety profile.&#xD;
      Collagen is a protein that is found in all mammals. The CollaRx Bupivacaine implant is a thin&#xD;
      flat sponge made out of collagen that comes from cow tendons and contains bupivacaine. When&#xD;
      inserted into a surgical site, the collagen breaks down and bupivacaine is released at the&#xD;
      site but very little is absorbed into the blood stream. The high levels of bupivacaine at the&#xD;
      surgical site may result in less pain for several days after surgery.&#xD;
&#xD;
      This study will compare the amount of narcotic pain medication required after surgery in&#xD;
      patients who receive the CollaRx Bupivacaine implant, a plain collagen implant or no implant&#xD;
      at all.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 27, 2007</start_date>
  <completion_date type="Actual">September 5, 2008</completion_date>
  <primary_completion_date type="Actual">September 5, 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Use of Opioid Rescue Analgesia</measure>
    <time_frame>0 to 24 hours postoperatively</time_frame>
    <description>Total use of opioid rescue analgesia (mg equivalent) -higher score means more analgesia was needed and worse outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Use of Opioid Rescue Analgesia</measure>
    <time_frame>0 to 48 hours postoperatively</time_frame>
    <description>Total use of opioid rescue analgesia (mg equivalent) -higher score means more analgesia was needed and worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Use of Opioid Rescue Analgesia</measure>
    <time_frame>0 to 72 hours postoperatively</time_frame>
    <description>Total use of opioid rescue analgesia (mg equivalent) -higher score means more analgesia was needed and worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity Rating on a Visual Analog Scale (at Rest)</measure>
    <time_frame>At 1, 1.5, 2, 3, 6, 9, 12, 18, 24, 36, 48 and 72 hours post operatively</time_frame>
    <description>Pain intensity rating on a Visual Analog Scale (at rest). Lowest score possible is &quot;0&quot; with the highest score possible being &quot;100&quot;. Higher number means more pain reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Use of Opioid Rescue Analgesia</measure>
    <time_frame>Actual time assessed during post operative period</time_frame>
    <description>Time to first use of opioid rescue analgesia - lower number means worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity Rating on a Visual Analog Scale (After Cough)</measure>
    <time_frame>At 1, 1.5, 2, 3, 6, 9, 12, 18, 24, 36, 48 and 72 hours post operatively</time_frame>
    <description>Pain intensity rating on a Visual Analog Scale (after cough). Lowest score possible is &quot;0&quot; with the highest score possible being &quot;100&quot;. Higher number means more pain reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity Rating on a 4-point Likert Scale (at Rest)</measure>
    <time_frame>At 1, 1.5, 2, 3, 6, 9, 12, 18, 24, 36, 48 and 72 hours post operatively</time_frame>
    <description>For the 4-point categorical scale assessment, patients measured their pain intensity at rest using a numerical scale where: 0 = &quot;none,&quot; 1 = &quot;mild,&quot; 2 = &quot;moderate&quot; and 3 = &quot;severe.&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity Rating on a 4-point Likert Scale (After Cough)</measure>
    <time_frame>At 1, 1.5, 2, 3, 6, 9, 12, 18, 24, 36, 48 and 72 hours post operatively</time_frame>
    <description>For the 4-point categorical scale assessment, patients measured their pain intensity after aggravated movement (cough) using a numerical scale where: 0 = &quot;none,&quot; 1 = &quot;mild,&quot; 2 = &quot;moderate&quot; and 3 = &quot;severe.&quot;</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A total of three 5 × 5-cm bupivacaine sponges implanted at specified layers in the wound prior to wound closure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A total of three 5 × 5-cm collagen sponges implanted at specified layers in the wound prior to wound closure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The patient will recieve the standard of care, but no implant during surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Collagen Sponge (CollaRx®)</intervention_name>
    <description>The bupivacaine sponge contains 70 mg Type I collagen and 50 mg bupivacaine hydrochloride. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>CollRx Bupivacaine Implant</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>The placebo sponge contains 70 mg Type I collagen. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have a body mass index (BMI) &gt; 19 and &lt; 40 kg/m2&#xD;
&#xD;
          -  Had planned an elective total abdominal hysterectomy for reasons other than&#xD;
             malignancies to be performed according to standard surgical technique using a standard&#xD;
             incision and under general anesthesia with the following caveats:&#xD;
&#xD;
               1. Laparoscopic procedures or supraumbilical or Maylard incisions will not be&#xD;
                  allowed&#xD;
&#xD;
               2. A nonlaparoscopic incision for benign non-hysterectomy gynecological procedures&#xD;
                  (such as myomectomy or adnexal surgery) is acceptable if the surgical indication&#xD;
                  is not to treat pelvic pain&#xD;
&#xD;
               3. No concomitant vaginal procedures are allowed. An abdominal urethropexy and an&#xD;
                  incidental appendectomy will be allowed&#xD;
&#xD;
          -  Have a risk classification of I, II or III according to the American Society of&#xD;
             Anesthesiologists (ASA)&#xD;
&#xD;
          -  Have a negative pregnancy test&#xD;
&#xD;
          -  Be free of other physical or mental conditions which may confound assessment of&#xD;
             postoperative pain&#xD;
&#xD;
          -  Have the ability to read, understand and comply with the study procedures and the use&#xD;
             of the pain scales; is capable of operating a patient-controlled analgesia (PCA)&#xD;
             device; and is able to communicate meaningfully with the study staff&#xD;
&#xD;
          -  Voluntarily sign and date an informed consent form (ICF), prior to the conduct of any&#xD;
             study-specific procedures&#xD;
&#xD;
          -  Able to fluently speak and understand English and be able to provide meaningful&#xD;
             written informed consent for the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known hypersensitivity to any active or inactive ingredient of the test articles&#xD;
&#xD;
          -  Presence of clinically significant cardiac arrhythmias or atrioventricular (AV)&#xD;
             conduction disorders&#xD;
&#xD;
          -  Concomitant use of other amide local anesthetics&#xD;
&#xD;
          -  Concomitant use of antiarrhythmics&#xD;
&#xD;
          -  Concomitant use of propanolol&#xD;
&#xD;
          -  Concomitant use of strong/moderate CYP3A4 inhibitors or inducers&#xD;
&#xD;
          -  Has used aspirin or aspirin-containing products within 7 days of surgery.&#xD;
&#xD;
          -  Previous major surgery in the last 3 months&#xD;
&#xD;
          -  Requires any additional surgical procedures during the same hospitalization (except as&#xD;
             noted)&#xD;
&#xD;
          -  Received neuraxial (spinal or epidural) opioid analgesics either prior to or during&#xD;
             surgery&#xD;
&#xD;
          -  Received local anesthetic infiltration of the surgical wound prior to, during or&#xD;
             immediately after closure&#xD;
&#xD;
          -  Is scheduled to receive local anesthetics via an indwelling catheter after surgery&#xD;
&#xD;
          -  Underwent additional procedures during surgery, which may increase the visceral pain&#xD;
&#xD;
          -  Has known or suspected history of alcohol or drug abuse or misuse or evidence for&#xD;
             tolerance or physical dependency on opioids analgesics or sedative-hypnotic&#xD;
             medications&#xD;
&#xD;
          -  Uses opioids or tramadol daily for &gt; 7 days prior to test article administration&#xD;
&#xD;
          -  Has impaired liver function&#xD;
&#xD;
          -  Has any clinically significant unstable condition that could compromise the patient's&#xD;
             welfare&#xD;
&#xD;
          -  Is at risk for infection or slow wound healing&#xD;
&#xD;
          -  Has a chronic painful condition that might confound the assessment of pain associated&#xD;
             with the sugery&#xD;
&#xD;
          -  Has taken pain medication that could confound the analgesic responses the day of&#xD;
             surgery&#xD;
&#xD;
          -  Has been treated within 2 weeks of surgery with agents that could affect the analgesic&#xD;
             response&#xD;
&#xD;
          -  Has been treated with monoamine oxidase inhibitors (MAOIs) or MAOIs have been stopped&#xD;
             fewer than 10 days prior to surgery&#xD;
&#xD;
          -  Has been treated with corticosteroids or whose treatment with these has been stopped &lt;&#xD;
             7 days prior surgery (inhaled corticosteroids are acceptable)&#xD;
&#xD;
          -  Has participated in a clinical trial in the previous 30 days&#xD;
&#xD;
          -  Has been hemodynamically unstable at any point in the previous 4 weeks or becomes&#xD;
             hemodynamically unstable during surgery&#xD;
&#xD;
          -  Required blood transfusion in the previous month, except as related to uterine&#xD;
             bleeding caused by uterine fibroids.&#xD;
&#xD;
          -  Has hemoglobin levels &lt; 10 g/dL or &lt; 8 g/dL for patients with an anemia secondary to&#xD;
             heavy uterine bleeding caused by uterine fibroids.&#xD;
&#xD;
          -  Has platelet count &lt; 100,000/mm&#xD;
&#xD;
          -  Unreliable or incapable of complying with the protocol&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Prior</last_name>
    <role>Study Director</role>
    <affiliation>Innocoll</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Forsyth Medical Centre - OB Anesthesia</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>February 19, 2008</study_first_submitted>
  <study_first_submitted_qc>February 27, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 28, 2008</study_first_posted>
  <results_first_submitted>September 29, 2020</results_first_submitted>
  <results_first_submitted_qc>January 8, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">January 12, 2021</results_first_posted>
  <last_update_submitted>July 21, 2021</last_update_submitted>
  <last_update_submitted_qc>July 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Post Operative Pain</keyword>
  <keyword>Hysterectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Bupivacaine Sponges</title>
          <description>A total of three 5 × 5-cm bupivacaine sponges implanted at specified layers in the wound prior to wound closure&#xD;
Bupivacaine Collagen Sponge (CollaRx®): The bupivacaine sponge contains 70 mg Type I collagen and 50 mg bupivacaine hydrochloride. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
        </group>
        <group group_id="P2">
          <title>Collagen Sponges</title>
          <description>A total of three 5 × 5-cm collagen sponges implanted at specified layers in the wound prior to wound closure&#xD;
placebo: The placebo sponge contains 70 mg Type I collagen. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
        </group>
        <group group_id="P3">
          <title>Standard of Care no Implant</title>
          <description>The patient will receive the standard of care, but no implant during surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Intent-to-Treat Population</population>
      <group_list>
        <group group_id="B1">
          <title>Bupivacaine Sponges</title>
          <description>A total of three 5 × 5-cm bupivacaine sponges implanted at specified layers in the wound prior to wound closure&#xD;
Bupivacaine Collagen Sponge (CollaRx®): The bupivacaine sponge contains 70 mg Type I collagen and 50 mg bupivacaine hydrochloride. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
        </group>
        <group group_id="B2">
          <title>Collagen Sponges</title>
          <description>A total of three 5 × 5-cm collagen sponges implanted at specified layers in the wound prior to wound closure&#xD;
placebo: The placebo sponge contains 70 mg Type I collagen. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
        </group>
        <group group_id="B3">
          <title>Standard of Care no Implant</title>
          <description>The patient will receive the standard of care, but no implant during surgery</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="28"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="11"/>
            <count group_id="B4" value="54"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.3" spread="6.87"/>
                    <measurement group_id="B2" value="39.7" spread="7.06"/>
                    <measurement group_id="B3" value="42.9" spread="6.17"/>
                    <measurement group_id="B4" value="42.2" spread="42.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="54"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Use of Opioid Rescue Analgesia</title>
        <description>Total use of opioid rescue analgesia (mg equivalent) -higher score means more analgesia was needed and worse outcome</description>
        <time_frame>0 to 24 hours postoperatively</time_frame>
        <population>Intent-to-Treat Population</population>
        <group_list>
          <group group_id="O1">
            <title>Bupivacaine Sponges</title>
            <description>A total of three 5 × 5-cm bupivacaine sponges implanted at specified layers in the wound prior to wound closure&#xD;
Bupivacaine Collagen Sponge (CollaRx®): The bupivacaine sponge contains 70 mg Type I collagen and 50 mg bupivacaine hydrochloride. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O2">
            <title>Collagen Sponges</title>
            <description>A total of three 5 × 5-cm collagen sponges implanted at specified layers in the wound prior to wound closure&#xD;
placebo: The placebo sponge contains 70 mg Type I collagen. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O3">
            <title>Standard of Care no Implant</title>
            <description>The patient will receive the standard of care, but no implant during surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Total Use of Opioid Rescue Analgesia</title>
          <description>Total use of opioid rescue analgesia (mg equivalent) -higher score means more analgesia was needed and worse outcome</description>
          <population>Intent-to-Treat Population</population>
          <units>mg morphine equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.65" spread="32.78"/>
                    <measurement group_id="O2" value="66.56" spread="47.53"/>
                    <measurement group_id="O3" value="53.73" spread="47.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Use of Opioid Rescue Analgesia</title>
        <description>Total use of opioid rescue analgesia (mg equivalent) -higher score means more analgesia was needed and worse outcome</description>
        <time_frame>0 to 48 hours postoperatively</time_frame>
        <population>Intent-to-Treat Population</population>
        <group_list>
          <group group_id="O1">
            <title>Bupivacaine Sponges</title>
            <description>A total of three 5 × 5-cm bupivacaine sponges implanted at specified layers in the wound prior to wound closure&#xD;
Bupivacaine Collagen Sponge (CollaRx®): The bupivacaine sponge contains 70 mg Type I collagen and 50 mg bupivacaine hydrochloride. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O2">
            <title>Collagen Sponges</title>
            <description>A total of three 5 × 5-cm collagen sponges implanted at specified layers in the wound prior to wound closure&#xD;
placebo: The placebo sponge contains 70 mg Type I collagen. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O3">
            <title>Standard of Care no Implant</title>
            <description>The patient will receive the standard of care, but no implant during surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Total Use of Opioid Rescue Analgesia</title>
          <description>Total use of opioid rescue analgesia (mg equivalent) -higher score means more analgesia was needed and worse outcome</description>
          <population>Intent-to-Treat Population</population>
          <units>mg morphine equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.78" spread="37.195"/>
                    <measurement group_id="O2" value="80.87" spread="51.085"/>
                    <measurement group_id="O3" value="66.03" spread="32.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Use of Opioid Rescue Analgesia</title>
        <description>Total use of opioid rescue analgesia (mg equivalent) -higher score means more analgesia was needed and worse outcome</description>
        <time_frame>0 to 72 hours postoperatively</time_frame>
        <population>Intent-to-Treat Population</population>
        <group_list>
          <group group_id="O1">
            <title>Bupivacaine Sponges</title>
            <description>A total of three 5 × 5-cm bupivacaine sponges implanted at specified layers in the wound prior to wound closure&#xD;
Bupivacaine Collagen Sponge (CollaRx®): The bupivacaine sponge contains 70 mg Type I collagen and 50 mg bupivacaine hydrochloride. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O2">
            <title>Collagen Sponges</title>
            <description>A total of three 5 × 5-cm collagen sponges implanted at specified layers in the wound prior to wound closure&#xD;
placebo: The placebo sponge contains 70 mg Type I collagen. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O3">
            <title>Standard of Care no Implant</title>
            <description>The patient will receive the standard of care, but no implant during surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Total Use of Opioid Rescue Analgesia</title>
          <description>Total use of opioid rescue analgesia (mg equivalent) -higher score means more analgesia was needed and worse outcome</description>
          <population>Intent-to-Treat Population</population>
          <units>mg morphine equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.13" spread="40.304"/>
                    <measurement group_id="O2" value="88.60" spread="55.84"/>
                    <measurement group_id="O3" value="73.28" spread="36.308"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Intensity Rating on a Visual Analog Scale (at Rest)</title>
        <description>Pain intensity rating on a Visual Analog Scale (at rest). Lowest score possible is &quot;0&quot; with the highest score possible being &quot;100&quot;. Higher number means more pain reported.</description>
        <time_frame>At 1, 1.5, 2, 3, 6, 9, 12, 18, 24, 36, 48 and 72 hours post operatively</time_frame>
        <population>Intent-to-Treat Population</population>
        <group_list>
          <group group_id="O1">
            <title>Bupivacaine Sponges</title>
            <description>A total of three 5 × 5-cm bupivacaine sponges implanted at specified layers in the wound prior to wound closure&#xD;
Bupivacaine Collagen Sponge (CollaRx®): The bupivacaine sponge contains 70 mg Type I collagen and 50 mg bupivacaine hydrochloride. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O2">
            <title>Collagen Sponges</title>
            <description>A total of three 5 × 5-cm collagen sponges implanted at specified layers in the wound prior to wound closure&#xD;
placebo: The placebo sponge contains 70 mg Type I collagen. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O3">
            <title>Standard of Care no Implant</title>
            <description>The patient will receive the standard of care, but no implant during surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Intensity Rating on a Visual Analog Scale (at Rest)</title>
          <description>Pain intensity rating on a Visual Analog Scale (at rest). Lowest score possible is &quot;0&quot; with the highest score possible being &quot;100&quot;. Higher number means more pain reported.</description>
          <population>Intent-to-Treat Population</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hour 1.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.5" spread="33.59"/>
                    <measurement group_id="O2" value="63.0" spread="30.08"/>
                    <measurement group_id="O3" value="66.5" spread="30.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 1.5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.1" spread="29.88"/>
                    <measurement group_id="O2" value="61.3" spread="31.48"/>
                    <measurement group_id="O3" value="61.3" spread="32.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 2.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.2" spread="23.92"/>
                    <measurement group_id="O2" value="50.3" spread="28.93"/>
                    <measurement group_id="O3" value="61.9" spread="28.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 3.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.0" spread="28.27"/>
                    <measurement group_id="O2" value="46.2" spread="31.80"/>
                    <measurement group_id="O3" value="46.4" spread="31.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 6.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.5" spread="24.47"/>
                    <measurement group_id="O2" value="43.3" spread="32.49"/>
                    <measurement group_id="O3" value="34.7" spread="27.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 9.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.2" spread="25.22"/>
                    <measurement group_id="O2" value="39.9" spread="31.49"/>
                    <measurement group_id="O3" value="44.0" spread="31.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.1" spread="24.79"/>
                    <measurement group_id="O2" value="32.4" spread="26.40"/>
                    <measurement group_id="O3" value="38.4" spread="32.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 18</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.6" spread="22.45"/>
                    <measurement group_id="O2" value="29.8" spread="29.78"/>
                    <measurement group_id="O3" value="24.0" spread="24.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" spread="24.71"/>
                    <measurement group_id="O2" value="32.0" spread="31.07"/>
                    <measurement group_id="O3" value="41.7" spread="39.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 36</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.6" spread="23.27"/>
                    <measurement group_id="O2" value="18.7" spread="18.40"/>
                    <measurement group_id="O3" value="41.8" spread="39.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 48</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.4" spread="20.41"/>
                    <measurement group_id="O2" value="26.7" spread="26.91"/>
                    <measurement group_id="O3" value="22.2" spread="29.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 72</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.6" spread="16.03"/>
                    <measurement group_id="O2" value="14.7" spread="17.43"/>
                    <measurement group_id="O3" value="27.7" spread="29.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Use of Opioid Rescue Analgesia</title>
        <description>Time to first use of opioid rescue analgesia - lower number means worse outcome</description>
        <time_frame>Actual time assessed during post operative period</time_frame>
        <population>Intent-to-Treat Population</population>
        <group_list>
          <group group_id="O1">
            <title>Bupivacaine Sponges</title>
            <description>A total of three 5 × 5-cm bupivacaine sponges implanted at specified layers in the wound prior to wound closure&#xD;
Bupivacaine Collagen Sponge (CollaRx®): The bupivacaine sponge contains 70 mg Type I collagen and 50 mg bupivacaine hydrochloride. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O2">
            <title>Collagen Sponges</title>
            <description>A total of three 5 × 5-cm collagen sponges implanted at specified layers in the wound prior to wound closure&#xD;
placebo: The placebo sponge contains 70 mg Type I collagen. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O3">
            <title>Standard of Care no Implant</title>
            <description>The patient will receive the standard of care, but no implant during surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Use of Opioid Rescue Analgesia</title>
          <description>Time to first use of opioid rescue analgesia - lower number means worse outcome</description>
          <population>Intent-to-Treat Population</population>
          <units>Time (Hours)</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" lower_limit="0.8" upper_limit="1.3"/>
                    <measurement group_id="O2" value="0.9" lower_limit="0.6" upper_limit="1.1"/>
                    <measurement group_id="O3" value="0.4" lower_limit="0.2" upper_limit="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Intensity Rating on a Visual Analog Scale (After Cough)</title>
        <description>Pain intensity rating on a Visual Analog Scale (after cough). Lowest score possible is &quot;0&quot; with the highest score possible being &quot;100&quot;. Higher number means more pain reported.</description>
        <time_frame>At 1, 1.5, 2, 3, 6, 9, 12, 18, 24, 36, 48 and 72 hours post operatively</time_frame>
        <population>Intent-to-Treat Population</population>
        <group_list>
          <group group_id="O1">
            <title>Bupivacaine Sponges</title>
            <description>A total of three 5 × 5-cm bupivacaine sponges implanted at specified layers in the wound prior to wound closure&#xD;
Bupivacaine Collagen Sponge (CollaRx®): The bupivacaine sponge contains 70 mg Type I collagen and 50 mg bupivacaine hydrochloride. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O2">
            <title>Collagen Sponges</title>
            <description>A total of three 5 × 5-cm collagen sponges implanted at specified layers in the wound prior to wound closure&#xD;
placebo: The placebo sponge contains 70 mg Type I collagen. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O3">
            <title>Standard of Care no Implant</title>
            <description>The patient will receive the standard of care, but no implant during surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Intensity Rating on a Visual Analog Scale (After Cough)</title>
          <description>Pain intensity rating on a Visual Analog Scale (after cough). Lowest score possible is &quot;0&quot; with the highest score possible being &quot;100&quot;. Higher number means more pain reported.</description>
          <population>Intent-to-Treat Population</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hour 1.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.2" spread="32.96"/>
                    <measurement group_id="O2" value="73.8" spread="33.55"/>
                    <measurement group_id="O3" value="72.6" spread="31.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 1.5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.2" spread="29.49"/>
                    <measurement group_id="O2" value="67.3" spread="34.05"/>
                    <measurement group_id="O3" value="73.8" spread="27.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 2.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.0" spread="24.96"/>
                    <measurement group_id="O2" value="61.3" spread="32.17"/>
                    <measurement group_id="O3" value="72.9" spread="26.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 3.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.9" spread="29.02"/>
                    <measurement group_id="O2" value="58.0" spread="32.82"/>
                    <measurement group_id="O3" value="59.0" spread="30.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 6.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.3" spread="27.73"/>
                    <measurement group_id="O2" value="64.7" spread="31.63"/>
                    <measurement group_id="O3" value="53.2" spread="29.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 9.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.8" spread="27.69"/>
                    <measurement group_id="O2" value="49.8" spread="29.12"/>
                    <measurement group_id="O3" value="63.1" spread="22.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.5" spread="24.56"/>
                    <measurement group_id="O2" value="49.1" spread="26.22"/>
                    <measurement group_id="O3" value="55.0" spread="27.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 18</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.8" spread="25.40"/>
                    <measurement group_id="O2" value="46.7" spread="28.79"/>
                    <measurement group_id="O3" value="45.3" spread="28.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.8" spread="26.65"/>
                    <measurement group_id="O2" value="52.0" spread="32.14"/>
                    <measurement group_id="O3" value="59.1" spread="30.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 36</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.2" spread="28.06"/>
                    <measurement group_id="O2" value="32.0" spread="23.81"/>
                    <measurement group_id="O3" value="58.2" spread="34.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 48</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.7" spread="29.30"/>
                    <measurement group_id="O2" value="46.8" spread="27.24"/>
                    <measurement group_id="O3" value="38.0" spread="27.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 72</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.0" spread="25.97"/>
                    <measurement group_id="O2" value="28.6" spread="27.94"/>
                    <measurement group_id="O3" value="40.1" spread="30.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Intensity Rating on a 4-point Likert Scale (at Rest)</title>
        <description>For the 4-point categorical scale assessment, patients measured their pain intensity at rest using a numerical scale where: 0 = &quot;none,&quot; 1 = &quot;mild,&quot; 2 = &quot;moderate&quot; and 3 = &quot;severe.&quot;</description>
        <time_frame>At 1, 1.5, 2, 3, 6, 9, 12, 18, 24, 36, 48 and 72 hours post operatively</time_frame>
        <population>Intent-to-Treat Population</population>
        <group_list>
          <group group_id="O1">
            <title>Bupivacaine Sponges</title>
            <description>A total of three 5 × 5-cm bupivacaine sponges implanted at specified layers in the wound prior to wound closure&#xD;
Bupivacaine Collagen Sponge (CollaRx®): The bupivacaine sponge contains 70 mg Type I collagen and 50 mg bupivacaine hydrochloride. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O2">
            <title>Collagen Sponges</title>
            <description>A total of three 5 × 5-cm collagen sponges implanted at specified layers in the wound prior to wound closure&#xD;
placebo: The placebo sponge contains 70 mg Type I collagen. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O3">
            <title>Standard of Care no Implant</title>
            <description>The patient will receive the standard of care, but no implant during surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Intensity Rating on a 4-point Likert Scale (at Rest)</title>
          <description>For the 4-point categorical scale assessment, patients measured their pain intensity at rest using a numerical scale where: 0 = &quot;none,&quot; 1 = &quot;mild,&quot; 2 = &quot;moderate&quot; and 3 = &quot;severe.&quot;</description>
          <population>Intent-to-Treat Population</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hour 0.5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="1.00"/>
                    <measurement group_id="O2" value="2.0" spread="1.00"/>
                    <measurement group_id="O3" value="2.2" spread="1.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 1.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="0.95"/>
                    <measurement group_id="O2" value="2.2" spread="0.69"/>
                    <measurement group_id="O3" value="2.2" spread="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 1.5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="0.79"/>
                    <measurement group_id="O2" value="2.0" spread="0.88"/>
                    <measurement group_id="O3" value="2.1" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 2.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="0.62"/>
                    <measurement group_id="O2" value="1.7" spread="0.70"/>
                    <measurement group_id="O3" value="2.0" spread="0.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 3.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="0.71"/>
                    <measurement group_id="O2" value="1.6" spread="0.74"/>
                    <measurement group_id="O3" value="1.9" spread="0.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 6.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.64"/>
                    <measurement group_id="O2" value="1.3" spread="0.96"/>
                    <measurement group_id="O3" value="1.6" spread="0.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 9.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="0.63"/>
                    <measurement group_id="O2" value="1.5" spread="0.83"/>
                    <measurement group_id="O3" value="1.8" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="0.75"/>
                    <measurement group_id="O2" value="1.1" spread="0.64"/>
                    <measurement group_id="O3" value="1.7" spread="0.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 18</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.51"/>
                    <measurement group_id="O2" value="1.1" spread="0.74"/>
                    <measurement group_id="O3" value="1.4" spread="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="0.75"/>
                    <measurement group_id="O2" value="1.1" spread="0.70"/>
                    <measurement group_id="O3" value="1.5" spread="0.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 36</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="0.82"/>
                    <measurement group_id="O2" value="0.8" spread="0.43"/>
                    <measurement group_id="O3" value="1.4" spread="0.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 48</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="0.63"/>
                    <measurement group_id="O2" value="0.9" spread="0.70"/>
                    <measurement group_id="O3" value="0.9" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 72</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="0.69"/>
                    <measurement group_id="O2" value="0.6" spread="0.63"/>
                    <measurement group_id="O3" value="1.1" spread="0.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Intensity Rating on a 4-point Likert Scale (After Cough)</title>
        <description>For the 4-point categorical scale assessment, patients measured their pain intensity after aggravated movement (cough) using a numerical scale where: 0 = &quot;none,&quot; 1 = &quot;mild,&quot; 2 = &quot;moderate&quot; and 3 = &quot;severe.&quot;</description>
        <time_frame>At 1, 1.5, 2, 3, 6, 9, 12, 18, 24, 36, 48 and 72 hours post operatively</time_frame>
        <population>Intent-to-Treat Population</population>
        <group_list>
          <group group_id="O1">
            <title>Bupivacaine Sponges</title>
            <description>A total of three 5 × 5-cm bupivacaine sponges implanted at specified layers in the wound prior to wound closure&#xD;
Bupivacaine Collagen Sponge (CollaRx®): The bupivacaine sponge contains 70 mg Type I collagen and 50 mg bupivacaine hydrochloride. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O2">
            <title>Collagen Sponges</title>
            <description>A total of three 5 × 5-cm collagen sponges implanted at specified layers in the wound prior to wound closure&#xD;
placebo: The placebo sponge contains 70 mg Type I collagen. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
          </group>
          <group group_id="O3">
            <title>Standard of Care no Implant</title>
            <description>The patient will receive the standard of care, but no implant during surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Intensity Rating on a 4-point Likert Scale (After Cough)</title>
          <description>For the 4-point categorical scale assessment, patients measured their pain intensity after aggravated movement (cough) using a numerical scale where: 0 = &quot;none,&quot; 1 = &quot;mild,&quot; 2 = &quot;moderate&quot; and 3 = &quot;severe.&quot;</description>
          <population>Intent-to-Treat Population</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hour 0.5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="1.02"/>
                    <measurement group_id="O2" value="2.2" spread="0.83"/>
                    <measurement group_id="O3" value="2.4" spread="0.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 1.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="0.95"/>
                    <measurement group_id="O2" value="2.5" spread="0.78"/>
                    <measurement group_id="O3" value="2.4" spread="0.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 1.5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="0.83"/>
                    <measurement group_id="O2" value="2.2" spread="0.80"/>
                    <measurement group_id="O3" value="2.5" spread="0.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 2.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="0.66"/>
                    <measurement group_id="O2" value="2.0" spread="0.93"/>
                    <measurement group_id="O3" value="2.3" spread="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 3.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="0.80"/>
                    <measurement group_id="O2" value="2.1" spread="0.88"/>
                    <measurement group_id="O3" value="2.2" spread="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 6.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="0.75"/>
                    <measurement group_id="O2" value="2.1" spread="0.74"/>
                    <measurement group_id="O3" value="2.1" spread="0.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 9.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="0.74"/>
                    <measurement group_id="O2" value="2.1" spread="0.80"/>
                    <measurement group_id="O3" value="2.2" spread="0.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="0.91"/>
                    <measurement group_id="O2" value="1.8" spread="0.69"/>
                    <measurement group_id="O3" value="2.0" spread="0.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 18</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="0.73"/>
                    <measurement group_id="O2" value="1.9" spread="0.74"/>
                    <measurement group_id="O3" value="1.7" spread="0.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="0.76"/>
                    <measurement group_id="O2" value="1.8" spread="0.77"/>
                    <measurement group_id="O3" value="1.9" spread="0.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 36</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="0.87"/>
                    <measurement group_id="O2" value="1.4" spread="0.76"/>
                    <measurement group_id="O3" value="1.9" spread="0.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 48</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.84"/>
                    <measurement group_id="O2" value="1.5" spread="0.92"/>
                    <measurement group_id="O3" value="1.5" spread="0.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 72</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="0.68"/>
                    <measurement group_id="O2" value="1.3" spread="0.49"/>
                    <measurement group_id="O3" value="1.3" spread="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Bupivacaine Sponges</title>
          <description>A total of three 5 × 5-cm bupivacaine sponges implanted at specified layers in the wound prior to wound closure&#xD;
Bupivacaine Collagen Sponge (CollaRx®): The bupivacaine sponge contains 70 mg Type I collagen and 50 mg bupivacaine hydrochloride. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
        </group>
        <group group_id="E2">
          <title>Collagen Sponges</title>
          <description>A total of three 5 × 5-cm collagen sponges implanted at specified layers in the wound prior to wound closure&#xD;
placebo: The placebo sponge contains 70 mg Type I collagen. A total of 3 sponges will be implanted during surgery; one sponge divided between areas in the vault, one sponge divided and placed across the incision in the peritoneum and the final sponge divided and placed between the sheath and skin around the incision.</description>
        </group>
        <group group_id="E3">
          <title>Standard of Care no Implant</title>
          <description>The patient will receive the standard of care, but no implant during surgery</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (11.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (11.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="28"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="11"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="28"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="15"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="11"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="28"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="28"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="11"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="28"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
              </event>
              <event>
                <sub_title>Oxygen saturation decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Procedural hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="28"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="28"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management</name_or_title>
      <organization>Innocoll</organization>
      <phone>484-406-5211</phone>
      <email>ctucker@innocoll.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

